Signum Surgical: Improving fecal incontinence treatment
Signum Surgical announced last month that it had raised $3 million in grants to help fund its efforts to gain U.S. and European regulatory clearance of a device intended to treat a condition that can cause fecal incontinence.
Company officials say their BioHealx technology is meant to overcome the ongoing infections and multiple procedures involved with present treatments. BioHealx includes a bioabsorbable implant that helps seal the fistula tract. Implanted during a minimally invasive, outpatient procedure, it dissolves in the body after treatment.